Completed PHASE4 INTERVENTIONAL 2-arm NCT00800553

fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived Adults

The Neural and Behavioral Correlates of How Donepezil Modulates Memory and Inhibitory Efficiency in the Context of 24 Hours of Sleep Deprivation

Sponsor: Duke-NUS Graduate Medical School

Conditions Sleep Deprivation

Interventions Placebo donepezil

Updated 5 times since 2017 Last updated: Aug 2, 2016 Started: Nov 30, 2006 Primary completion: May 31, 2007 Completion: May 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Sleep Deprivation and is currently completed. Duke-NUS Graduate Medical School leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Duke-NUS Graduate Medical School
GlaxoSmithKline

Data source: Duke-NUS Graduate Medical School

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Singapore, Singapore